180 related articles for article (PubMed ID: 10821785)
1. Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo.
Wegener G; Volke V; Rosenberg R
Br J Pharmacol; 2000 Jun; 130(3):575-80. PubMed ID: 10821785
[TBL] [Abstract][Full Text] [Related]
2. Intracerebroventricular administration of nitric oxide-sensitive guanylyl cyclase inhibitors induces catalepsy in mice.
Echeverry MB; Salgado ML; Ferreira FR; da-Silva CA; Del Bel EA
Psychopharmacology (Berl); 2007 Oct; 194(2):271-8. PubMed ID: 17593355
[TBL] [Abstract][Full Text] [Related]
3. In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway.
Fedele E; Jin Y; Varnier G; Raiteri M
Br J Pharmacol; 1996 Oct; 119(3):590-4. PubMed ID: 8894183
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide modulates lithium-induced conditioned taste aversion.
Wegener G; Volke V; Bandpey Z; Rosenberg R
Behav Brain Res; 2001 Jan; 118(2):195-200. PubMed ID: 11164517
[TBL] [Abstract][Full Text] [Related]
5. Galanin stimulates the N-methyl-D-aspartate receptor/nitric oxide/cyclic GMP pathway in vivo in the rat ventral hippocampus.
Consolo S; Uboldi MC; Caltavuturo C; Bartfai T
Neuroscience; 1998 Aug; 85(3):819-26. PubMed ID: 9639275
[TBL] [Abstract][Full Text] [Related]
6. Effects of 7-nitroindazole, an NOS inhibitor on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in mice.
Ali SF; Itzhak Y
Ann N Y Acad Sci; 1998 May; 844():122-30. PubMed ID: 9668670
[TBL] [Abstract][Full Text] [Related]
7. Endogenous nitric oxide facilitates striatal dopamine and glutamate efflux in vivo: role of ionotropic glutamate receptor-dependent mechanisms.
West AR; Galloway MP
Neuropharmacology; 1997; 36(11-12):1571-81. PubMed ID: 9517428
[TBL] [Abstract][Full Text] [Related]
8. Regulatory role of nitric oxide over hippocampal 5-HT release in vivo.
Segieth J; Pearce B; Fowler L; Whitton PS
Naunyn Schmiedebergs Arch Pharmacol; 2001 Mar; 363(3):302-6. PubMed ID: 11284445
[TBL] [Abstract][Full Text] [Related]
9. Evidence that the neuronal nitric oxide synthase inhibitor 7-nitroindazole inhibits monoamine oxidase in the rat: in vivo effects on extracellular striatal dopamine and 3,4-dihydroxyphenylacetic acid.
Desvignes C; Bert L; Vinet L; Denoroy L; Renaud B; Lambás-Señas L
Neurosci Lett; 1999 Feb; 261(3):175-8. PubMed ID: 10081977
[TBL] [Abstract][Full Text] [Related]
10. Release of arginine, glutamate and glutamine in the hippocampus of freely moving rats: Involvement of nitric oxide.
Watts J; Fowler L; Whitton PS; Pearce B
Brain Res Bull; 2005 May; 65(6):521-8. PubMed ID: 15862924
[TBL] [Abstract][Full Text] [Related]
11. Evidence that the neuronal nitric oxide synthase inhibitor 7-nitroindazole inhibits monoamine oxidase in the rat: in vivo effects on extracellular striatal dopamine and 3,4-dihydroxyphenylacetic acid.
Desvignes C; Bert L; Vinet L; Denoroy L; Renaud B; Lambás-Señas L
Neurosci Lett; 1999 Apr; 264(1-3):5-8. PubMed ID: 10320000
[TBL] [Abstract][Full Text] [Related]
12. Regulatory role of nitric oxide over extracellular taurine in the hippocampus of freely moving rats.
Watts J; Segieth J; Pearce B; Whitton PS
Neurosci Lett; 2004 Mar; 357(3):179-82. PubMed ID: 15003279
[TBL] [Abstract][Full Text] [Related]
13. Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats.
Heiberg IL; Wegener G; Rosenberg R
Behav Brain Res; 2002 Aug; 134(1-2):479-84. PubMed ID: 12191834
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of vasoactive intestinal peptide (VIP) in the dentate gyrus and hippocampus via the NO-cGMP pathway following kainic acid-induced seizure in the rat.
Cosgrave AS; McKay JS; Thippeswamy T
J Mol Neurosci; 2010 Nov; 42(3):359-69. PubMed ID: 20369387
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide can differentially modulate striatal neurotransmitter concentrations via soluble guanylate cyclase and peroxynitrite formation.
Trabace L; Kendrick KM
J Neurochem; 2000 Oct; 75(4):1664-74. PubMed ID: 10987848
[TBL] [Abstract][Full Text] [Related]
16. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
[TBL] [Abstract][Full Text] [Related]
17. Anxiolytic effects induced by inhibition of the nitric oxide-cGMP pathway in the rat dorsal hippocampus.
Spolidório PC; Echeverry MB; Iyomasa M; Guimarães FS; Del Bel EA
Psychopharmacology (Berl); 2007 Dec; 195(2):183-92. PubMed ID: 17661019
[TBL] [Abstract][Full Text] [Related]
18. 7-Nitroindazole, a selective inhibitor of nNOS, increases hippocampal extracellular glutamate concentration in status epilepticus induced by kainic acid in rats.
Alabadí JA; Thibault JL; Pinard E; Seylaz J; Lasbennes F
Brain Res; 1999 Aug; 839(2):305-12. PubMed ID: 10519054
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide regulates NMDA-induced dopamine release in rat striatum.
Shibata M; Araki N; Ohta K; Hamada J; Shimazu K; Fukuuchi Y
Neuroreport; 1996 Jan; 7(2):605-8. PubMed ID: 8730840
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide increases dopamine and serotonin release in the medial preoptic area.
Lorrain DS; Hull EM
Neuroreport; 1993 Oct; 5(1):87-9. PubMed ID: 8280866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
